Monitoring the decreasing trend of testicular cancer mortality in Spain during 2005-2019 through a Bayesian approach

Cancer Epidemiology

Volumn 34, Issue 3, 2010, Pages 244-256

  Clèries, Ramon ^a,b   Martínez, José Miguel ^c   Escribà, Josep Maria ^a   Esteban, Laura ^a   Pareja, Laura ^a   Borràs, Josep Maria ^a,b   Ribes, Josepa ^a,b  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Bayesian; Mortality; Projections; Testicular cancer; Time trends

Indexed keywords

ACCURACY; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BAYES THEOREM; CALCULATION; CANCER EPIDEMIOLOGY; CANCER MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; SPAIN; TESTIS CANCER; TREND STUDY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BAYES THEOREM; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; MORTALITY; POPULATION SURVEILLANCE; SPAIN; TESTICULAR NEOPLASMS; YOUNG ADULT;

EID: 77952240926     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2010.03.003     Document Type: Article

References (44)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 3 (2007) 581-592
2. Bray F., Richiardi L., Ekbom A., Pukkala E., Cuninkova M., and Moller H. Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118 12 (2006) 3099-3111
3. Huyghe E., Plante P., and Thonneau P.F. Testicular cancer variations in time and space in Europe. Eur Urol 51 3 (2007) 621-628
4. Richiardi L., Akre O., Lambe M., Granath F., Montgomery S.M., and Ekbom A. Birth order, sib ship size, and risk for germ-cell testicular cancer. Epidemiology 15 3 (2004) 323-329
5. Hsieh C.C., Lambe M., Trichopoulos D., Ekbom A., Akre O., and Adami H.O. Early life exposure to oestrogen and testicular cancer risk: evidence against an aetiological hypothesis. Br J Cancer 86 8 (2002) 1363-1364
6. Moller H., Jorgensen N., and Forman D. Trends in incidence of testicular cancer in boys and adolescent men. Int J Cancer 61 6 (1995) 761-764
7. Akre O., Lipworth L., Cnattingius S., Sparen P., and Ekbom A. Risk factor patterns for cryptorchidism and hypospadias. Epidemiology 10 4 (1999) 364-369
8. Pettersson A., Kaijser M., Richiardi L., Askling J., Ekbom A., and Akre O. Women smoking and testicular cancer: one epidemic causing another?. Int J Cancer 109 6 (2004) 941-944
9. Weir H.K., Marrett L.D., Kreiger N., Darlington G.A., and Sugar L. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 87 3 (2000) 438-443
10. Alfonso J.L., Cortes C., Gimenez F., and Cortina P. Cancer of the testis: risk factors and evolution of mortality in Spain (1951-1983). Arch Esp Urol 42 8 (1989) 755-760
11. Fernandez Q.G., Monge J.V., Lopez-Abente O.G., and Vincente Perez J.A. Transitory trends in the mortality of testicular cancer in Spain 1953-1977. Actas Urol Esp 12 4 (1988) 340-346
12. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., and Coebergh J.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the. Eur J Cancer (1990) 2008
13. Spiegelhalter D.J., Thomas A., Best N., and Lunn D. WinBUGS User Manual, Version 1.4 (2002), MRC Biostatistics Unit, Cambridge, England
14. R Development Core Team. R: A language and environment for statistical computing, R Foundation for Statistical Computing, Vienna, Austria, 2006. ISBN 3-900051-07-0. http://www.R-project.org 2006; Available at: URL: http://www.R-project.org.
15. Sturtz S., Ligges U., and Gelman A. R2WinBUGS: a package for running WinBUGS from R. J Stat Soft 12 3 (2005) 1-16
16. World Health Organization. International classification of diseases, Tenth Revision (ICD-10) (1992), WHO, Geneva
17. Clayton D., and Schifflers E. Models for temporal variation in cancer rates. II. Age-period-cohort models. Stat Med 6 4 (1987) 469-481
18. Bashir S.A., and Estève J. Projecting cancer incidence and mortality using Bayesian age-period. Cohort models. J Epidemiol Biostat 6 (2001) 287-296
19. Knorr-Held L., and Rainer E. Projections of lung cancer mortality in West Germany: a case study in Bayesian prediction. Biostatistics 2 1 (2001) 109-129
20. Cleries R., Ribes J., Esteban L., Martinez J.M., and Borras J.M. Time trends of breast cancer mortality in Spain during the period 1977-2001 and Bayesian approach for projections during 2002-2016. Ann Oncol 17 12 (2006) 1783-1791
21. Gelman A. Prior distributions for variance parameters in hierarchical models. Bayesian Anal 1 (2005) 1-19
22. Spiegelhalter D.J., Best N.G., Carlin B.P., van der Linde A.J., and Bayesian. Measures of model complexity and fit (with discussion). J Roy Stat Soc Ser B 64 3 (2002) 583-639
23. Holford T.R. The estimation of age, period and cohort effects for vital rates. Biometrics 39 (1983) 311-324
24. Holford T.R. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Publ Health 12 (1991) 425-457
25. Holford T.R. An alternative approach to statistical age-period-cohort analysis. J Chronic Dis 38 10 (1985) 831-840
26. Holford T.R. Analysing the temporal effects of age, period and cohort. Stat Methods Med Res 1 3 (1992) 317-337
27. Einhorn L.H., and Donohue J. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87 3 (1977) 293-298
28. Becker N., and Boyle P. Decline in mortality from testicular cancer in West Germany after reunification. Lancet 350 9079 (1997) 744
29. Thornhill J.A., Conroy R.M., Kelly D.G., Walsh A., Fennelly J.J., and Fitzpatrick J.M. Recent trends in mortality due to testicular cancer in Ireland: a comparison with England and Wales. J Epidemiol Community Health 40 3 (1986) 218-222
30. Brown L.M., Pottern L.M., Hoover R.N., Devesa S.S., Aselton P., and Flannery J.T. Testicular cancer in the United States: trends in incidence and mortality. Int J Epidemiol 15 2 (1986) 164-170
31. Osterlind A. Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982. Br J Cancer 53 4 (1986) 501-505
32. Richiardi L., Bellocco R., Adami H.O., Torrang A., Barlow L., Hakulinen T., et al. Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13 (2004) 2157-2166
33. Peckham M.J., McElwain T.J., Barrett A., and Hendry W.F. Combined management of malignant teratoma of the testis. Lancet 2 8137 (1979) 267-270
34. Oliver R.T., Ong J., Blandy J.P., and Altman D.G. Testis conservation studies in germ cell cancer justified by improved primary chemotherapy response and reduced delay, 1978-1994. Br J Urol 78 1 (1996) 119-124
35. Cambil J. Effectiveness of testicular self-examination and screening for an early detection of testicular cancer. Index Enferm 14 (2005) 48-49
36. Webb V., and Holmes A. Urological cancers: do early detection strategies exist?. BJU Int 86 9 (2000) 996-1000
37. Sant M., Aareleid T., Artioli M.E., Berrino F., Coebergh J.W., Colonna M., et al. Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study. Eur J Cancer 43 3 (2007) 585-592
38. Einhorn L.H. Curing metastatic testicular cancer. Proc Natl Acad Sci USA 99 7 (2002) 4592-4595
39. Sant M., Aareleid T., Berrino F., Lasota M.B., Carli P.M., Faivre J., et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 14 Suppl. 5 (2003) v61-v118
40. Berrino F., De Angelis R., Sant M., Rosso S., Lasota M.B., Coebergh J.W., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8 9 (2007) 773-783
41. Berrino F., Capocaccia R., Estève J., Gatta G., Hakulinen T., Micheli A., et al. Survival of cancer patients in Europe: the EUROCARE-2 Study (1999), IARC Scientific Press
42. Eurostat. Non-national populations in the EU Member States. Eurostat Population and social conditions 2006; Issue number 8; Available at: URL: http://epp.eurostat.ec.europa.eu/cache/ITY_OFFPUB/KS-NK-06-008/EN/KS-NK-06-008-EN.PDF, Accessed on June 15, 2006.
43. Bray F., and Moller B. Predicting the future burden of cancer. Nat Rev Cancer 6 1 (2006) 63-74
44. Richie J.P. Impact of diagnostic delay in testis cancer: results of a large population-based study Huyghe E, Muller A, Mieusset R, Bujan L, Bachaud JM, Chevreau C, Plante P, Thonneau P, Human Fertility Research Group, Paule de Viguier Hospital, Toulouse University III, France; Urology and Andrology Department, Paule de Viguier Hospital, Toulouse, France. Urol Oncol 26 2 (2008) 220-221